Antioxidant nutrients and hemolysis in sickle cell disease.

Clinica Chimica Acta; International Journal of Clinical Chemistry
Emília DelesderrierMarta Citelli

Abstract

Hemolysis is one of the main pathophysiological characteristics of sickle cell disease (SCD) and might cause or could be the result of oxidative stress. Antioxidants are studied in SCD due to their potential to ensure redox balance and minimize deleterious effects on erythrocyte membranes. The objective of this systematic review was to evaluate the efficacy of antioxidant nutrient supplementation on reducing hemolysis in SCD patients through randomized clinical trials. We conducted our study according to the Preferred Reporting Items for Systematic Reviews and Meta-analyses and the Cochrane Handbook for Systematic Reviews of Interventions investigating whether antioxidants could improve the hemolytic status of SCD patients. This study included 587 articles published until April 2020. We reduced this pool to 12 articles by excluding duplicates, reviews, comments, and studies with non-human subjects. Omega-3 fatty acids, vitamin A, and zinc were the antioxidants that reportedly improved the indirect hemolysis parameters such as hemoglobin, hematocrit, mean corpuscular volume, or red blood cells. High-dose vitamin C and E supplementation worsened hemolysis, causing increased reticulocytes, lactate dehydrogenase, indirect bilirubin...Continue Reading

References

Jan 1, 1988·Proceedings of the National Academy of Sciences of the United States of America·R P HebbelB E Hedlund
May 1, 1980·The American Journal of Clinical Nutrition·C L NattaM Brin
Dec 1, 1982·The Journal of Clinical Investigation·R P HebbelM H Steinberg
Jan 15, 1981·The New England Journal of Medicine·A CohenE Schwartz
Jan 15, 1981·The New England Journal of Medicine·A W Nienhuis
Apr 18, 2003·American Journal of Hematology·Betty S PaceSteven R Goodman
Mar 31, 2004·European Journal of Nutrition·Angelo Azzi
Apr 7, 2005·JAMA : the Journal of the American Medical Association·Russell P RotherMark T Gladwin
Mar 9, 2006·Annals of Saudi Medicine·Rana M W Hasanato
Aug 5, 2008·Translational Research : the Journal of Laboratory and Clinical Medicine·Bin BaoPaul Swerdlow
Aug 16, 2008·Hematology·Michele Ana Flores ChavesAguinaldo José do Nascimento
May 6, 2009·American Journal of Hematology·Susan ClasterThomas D Coates
Dec 9, 2009·The FEBS Journal·Tamir Kanias, Jason P Acker
Dec 7, 2010·Lancet·David C ReesMark T Gladwin
Feb 10, 2012·Annals of Hematology·Erfan NurUNKNOWN CURAMA study group
Jun 29, 2013·Indian Journal of Medical Sciences·Shuchismita BeheraShantanu Kumar Kar
Jun 17, 2014·Clinica Chimica Acta; International Journal of Clinical Chemistry·Peramaiyan RajendranIkuo Nishigaki
Jun 30, 2014·Advances in Cancer Research·Yilin LiuJoseph J Barycki
Apr 11, 2015·Free Radical Biology & Medicine·Juan DuJoseph J Cullen
May 20, 2015·Journal of Pediatric Hematology/oncology·Kelly A DoughertyVirginia A Stallings
May 23, 2015·Biochemical and Biophysical Research Communications·Michael J Berridge
Jun 9, 2015·Pathophysiology : the Official Journal of the International Society for Pathophysiology·M O KehindeS I Jaja
Aug 19, 2015·Redox Biology·S VoskouM Kleanthous
May 4, 2016·Clinica Chimica Acta; International Journal of Clinical Chemistry·Katia Stankovic Stojanovic, François Lionnet
Mar 2, 2017·The Journal of Clinical Investigation·Gregory J KatoMark T Gladwin
May 31, 2017·Blood Cells, Molecules & Diseases·Abdu I Alayash
Jun 21, 2017·Nutrients·Nour Zahi Gammoh, Lothar Rink
Nov 18, 2017·Cellular Physiology and Biochemistry : International Journal of Experimental Cellular Physiology, Biochemistry, and Pharmacology·Long HeXi Ma
Mar 16, 2018·Nature Reviews. Disease Primers·Gregory J KatoElliott P Vichinsky
Jul 19, 2018·The New England Journal of Medicine·Yutaka NiiharaUNKNOWN Investigators of the Phase 3 Trial of l-Glutamine in Sickle Cell Disease
Oct 1, 2018·Free Radical Biology & Medicine·Charles Badu-Boateng, Richard J Naftalin
Oct 22, 2018·Advances in Clinical Chemistry·Garrett TeskeyVishwanath Venketaraman
Aug 10, 2019·Nutrients·Gabriela MarcelinoRita de Cássia Avellaneda Guimarães
Aug 30, 2019·BMJ : British Medical Journal·Jonathan A C SterneJulian P T Higgins
Sep 22, 2019·Nutrients·Emília DelesderrierMarta Citelli
Nov 26, 2019·Journal of Pediatric Hematology/oncology·Jefferson N BrownellVirginia A Stallings

❮ Previous
Next ❯

Related Concepts

Related Feeds

Anemia

Anemia develops when your blood lacks enough healthy red blood cells. Anemia of inflammation (AI, also called anemia of chronic disease) is a common, typically normocytic, normochromic anemia that is caused by an underlying inflammatory disease. Here is the latest research on anemia.

Blood And Marrow Transplantation

The use of hematopoietic stem cell transplantation or blood and marrow transplantation (bmt) is on the increase worldwide. BMT is used to replace damaged or destroyed bone marrow with healthy bone marrow stem cells. Here is the latest research on bone and marrow transplantation.

Related Papers

Current Opinion in Physiology
Deirdre Nolfi-DoneganCheryl A Hillery
Clinical Hemorheology and Microcirculation
Camille FaesRafal Pawlinski
© 2021 Meta ULC. All rights reserved